Intellia Therapeutics, Inc. · 1 day ago
Senior Research Associate, High-Throughput Genomics
Cambridge, MA
Full-time
Onsite
Mid, Senior Level
$87K/yr - $107K/yr
2+ years expIntellia Therapeutics, Inc. is dedicated to developing curative genome editing treatments for severe diseases. The Senior Research Associate will leverage genomics and automation capabilities to drive research forward, focusing on high-throughput NGS sequencing and collaborating with various teams to enhance genomic methodologies.
BiotechnologyGeneticsHealth CareMedicalTherapeutics
Responsibilities
Execute weekly high-throughput NGS amplicon sequencing library construction and sequencing runs
Work with liquid handling automation to support high-throughput workflows
Experimentally test and implement process improvements for amplicon sequencing and other genomics methods
Evaluate editing outcomes with ddPCR
Collaborate with team members, automation engineers, computational biologists, and programs/platform teams, applying genomics methods to answer research questions and troubleshoot problems
Monitor data quality metrics, ensuring consistent generation of high-quality data
Present and discuss work in team meetings
Qualification
Required
Hands-on experience with Illumina library construction, quantification, sequencing, and data QC
Solid foundation in and conceptual understanding of molecular biology techniques such as PCR, gel electrophoresis, DNA/RNA purification, and adapter ligation
Experience with liquid handling automation (preferably Hamilton)
Ability to build working relationships with internal 'customers' and a 'customer service' mindset, including troubleshooting, prioritization, and meeting timelines
Strong collaboration and documentation skills
BS or MS degree in molecular biology, biochemistry, or a related field
BS with 2-4 years or MS with 0-3 years of relevant experience (industry experience preferred)
Lift and move lab equipment up to 25 pounds
Manual dexterity to manipulate small items and reagent caps
Preferred
Experience in a high-throughput production environment
Benefits
Performance-based annual cash bonus
New hire equity grant
Eligibility to be considered for annual equity awards the value of which are determined annually at the Company’s discretion
Company
Intellia Therapeutics, Inc.
Intellia Therapeutics is a leading genome editing company whose mission is to develop potentially curative gene editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.
501-1000 employees
H1B Sponsorship
Intellia Therapeutics, Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (13)
2024 (38)
2023 (63)
2022 (46)
2021 (10)
2020 (6)
Funding
Current Stage
Public CompanyTotal Funding
$1.54BKey Investors
OrbiMed
2022-11-30Post Ipo Equity· $300M
2021-06-30Post Ipo Equity· $690M
2020-11-30Post Ipo Equity· $201M
Leadership Team
John Leonard
President and Chief Executive Officer, Member Board of Directors
Edward Dulac
Chief Financial Officer
Recent News
2025-12-29
EIN Presswire
2025-11-26
Company data provided by crunchbase